Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 619
5
Diseases
8
Unique genes
0.111
Avg. similarity score
Complex hereditary spastic paraplegia
Most-connected disease (4 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Complex hereditary spastic paraplegia
Spastic paraplegia 26, autosomal recessive
Spastic paraplegia 45, autosomal recessive
Spastic paraplegia 46, autosomal recessive
Spastic paraplegia 75, autosomal recessive
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Complex hereditary spastic paraplegia | 4 | 4 | 8 |
| Spastic paraplegia 26, autosomal recessive | 1 | 1 | 1 |
| Spastic paraplegia 45, autosomal recessive | 1 | 1 | 1 |
| Spastic paraplegia 46, autosomal recessive | 1 | 1 | 1 |
| Spastic paraplegia 75, autosomal recessive | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| B4GALNT1 | 2 / 5 | Complex hereditary spastic paraplegia, Spastic paraplegia 26, autosomal recessive |
| GBA2 | 2 / 5 | Complex hereditary spastic paraplegia, Spastic paraplegia 46, autosomal recessive |
| MAG | 2 / 5 | Complex hereditary spastic paraplegia, Spastic paraplegia 75, autosomal recessive |
| NT5C2 | 2 / 5 | Complex hereditary spastic paraplegia, Spastic paraplegia 45, autosomal recessive |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Glycosphingolipid metabolism | Reactome | 2 / 46 | 65.3× | 3.96e-4 | 5.58e-3 ✓ sig. |
| Sphingolipid metabolism | KEGG | 2 / 54 | 55.6× | 5.46e-4 | 7.15e-3 ✓ sig. |
| Pyrimidine metabolism | KEGG | 2 / 58 | 51.8× | 6.30e-4 | 7.99e-3 ✓ sig. |
| Nucleotide metabolism | KEGG | 2 / 85 | 35.3× | 1.35e-3 | 1.42e-2 ✓ sig. |
| Signaling by plasma membrane FGFR1 fusions | Reactome | 1 / 3 | 500× | 2.00e-3 | 1.90e-2 ✓ sig. |
| Abacavir metabolism | Reactome | 1 / 3 | 500× | 2.00e-3 | 1.90e-2 ✓ sig. |
| Purine metabolism | KEGG | 2 / 128 | 23.5× | 3.03e-3 | 2.56e-2 ✓ sig. |
| Phosphate bond hydrolysis by NTPDase proteins | Reactome | 1 / 8 | 188× | 5.32e-3 | 3.80e-2 ✓ sig. |
| Axonal growth inhibition (RHOA activation) | Reactome | 1 / 9 | 167× | 5.98e-3 | 4.10e-2 ✓ sig. |
| Purine catabolism | Reactome | 1 / 12 | 125× | 7.97e-3 | 4.94e-2 ✓ sig. |
| Membrane binding and targetting of GAG proteins | Reactome | 1 / 14 | 107× | 9.29e-3 | 5.43e-2 |
| Glycosphingolipid biosynthesis - ganglio series | KEGG | 1 / 15 | 100× | 9.95e-3 | 5.67e-2 |
| Other glycan degradation | KEGG | 1 / 18 | 83.4× | 1.19e-2 | 6.32e-2 |
| Metabolic pathways | KEGG | 4 / 1,563 | 3.8× | 1.29e-2 | 6.63e-2 |
| Purinergic signaling in leishmaniasis infection | Reactome | 1 / 24 | 62.6× | 1.59e-2 | 7.50e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| sphingolipid metabolic process | GO:0006665 | 2 / 59 | 79.2× | 2.71e-4 | 6.30e-3 ✓ sig. |
| GMP catabolic process to guanine | GO:0006202 | 1 / 1 | 2,336× | 4.28e-4 | 8.53e-3 ✓ sig. |
| purine ribonucleoside diphosphate catabolic process | GO:0009181 | 1 / 2 | 1,168× | 8.56e-4 | 1.33e-2 ✓ sig. |
| cholesterol metabolic process | GO:0008203 | 2 / 107 | 43.7× | 8.89e-4 | 1.37e-2 ✓ sig. |
| glucosylceramide catabolic process | GO:0006680 | 1 / 3 | 779× | 1.28e-3 | 1.67e-2 ✓ sig. |
| dGMP metabolic process | GO:0046054 | 1 / 3 | 779× | 1.28e-3 | 1.67e-2 ✓ sig. |
| ADP catabolic process | GO:0046032 | 1 / 3 | 779× | 1.28e-3 | 1.67e-2 ✓ sig. |
| steroid metabolic process | GO:0008202 | 2 / 135 | 34.6× | 1.41e-3 | 1.77e-2 ✓ sig. |
| IMP metabolic process | GO:0046040 | 1 / 4 | 584× | 1.71e-3 | 1.96e-2 ✓ sig. |
| negative regulation of defense response to virus by host | GO:0050689 | 1 / 4 | 584× | 1.71e-3 | 1.96e-2 ✓ sig. |
| nucleoside diphosphate catabolic process | GO:0009134 | 1 / 4 | 584× | 1.71e-3 | 1.96e-2 ✓ sig. |
| IMP catabolic process | GO:0006204 | 1 / 5 | 467× | 2.14e-3 | 2.19e-2 ✓ sig. |
| GMP catabolic process | GO:0046038 | 1 / 5 | 467× | 2.14e-3 | 2.19e-2 ✓ sig. |
| carbohydrate metabolic process | GO:0005975 | 2 / 175 | 26.7× | 2.35e-3 | 2.30e-2 ✓ sig. |
| central nervous system myelin formation | GO:0032289 | 1 / 6 | 389× | 2.57e-3 | 2.40e-2 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Complex hereditary spastic paraplegia | Spastic paraplegia 45, autosomal recessive | 0.111 | 1 | 5.17e-4 | 9.13e-4 ✓ sig. |
| Complex hereditary spastic paraplegia | Spastic paraplegia 26, autosomal recessive | 0.111 | 1 | 5.17e-4 | 9.13e-4 ✓ sig. |
| Complex hereditary spastic paraplegia | Spastic paraplegia 46, autosomal recessive | 0.111 | 1 | 5.17e-4 | 9.13e-4 ✓ sig. |
| Complex hereditary spastic paraplegia | Spastic paraplegia 75, autosomal recessive | 0.111 | 1 | 5.17e-4 | 9.13e-4 ✓ sig. |